Ali Yasmin, Leslie Zachary, Ahmed Khalid, Wise Eric, Freeman Martin, Amateau Stuart K, Dirweesh Ahmed
Department of Internal Medicine, Hennepin Healthcare, Minneapolis, MN, USA.
Carleton College, Northfield, MN, USA.
Dig Dis Sci. 2025 Jun 18. doi: 10.1007/s10620-025-09158-w.
The impact of weight management strategies on mortality and readmission in chronic pancreatitis patients remains unclear. This study uses the Nationwide Readmissions Database to assess the effects of prior bariatric surgery on these outcomes in patients with CP.
Patients with CP and severe obesity or history of bariatric surgery were extracted in the NRD from 2016 to 2022. Demographics, hospital/operative factors, and comorbidities were identified as independent risk factors. 90-day readmission and mortality were identified as outcomes. Univariate regressions determined differences in characteristics for patients with and without prior bariatric surgery, and independent risk factors were used to construct multivariable logistic regression models for these outcomes.
A total of 40,685 patients with CP and either severe obesity or history of bariatric surgery were identified, with 31.4% of patients having undergone prior bariatric surgery. Charlson comorbidity scores for CP patients with prior bariatric surgery were lower compared to individual with severe obesity alone (1.6 ± 1.7 vs. 2.85 ± 2.3). Bariatric surgery was associated with a higher risk of readmission (OR:1.77 [1.64,1.91], p < 0.05). While no significant difference in mortality was found between the two groups (5.4% vs 4.8% OR:1.10 [0.97,1.25], p = 0.15), protein malnutrition was associated with a significantly increased risk of mortality in postsurgical patients (OR: 2.35, 95% CI [2.06,2.70]).
Metabolic surgery increases the risk of readmission in patients with CP compared to obese CP patients who never underwent bariatric surgery. However, it does not alter mortality rates. Further prospective studies are needed to explore the underlying mechanisms and potential prevention strategies.
体重管理策略对慢性胰腺炎患者死亡率和再入院率的影响仍不明确。本研究使用全国再入院数据库评估既往减肥手术对慢性胰腺炎患者这些结局的影响。
2016年至2022年期间从全国再入院数据库中提取患有慢性胰腺炎且严重肥胖或有减肥手术史的患者。人口统计学、医院/手术因素和合并症被确定为独立危险因素。90天再入院率和死亡率被确定为结局指标。单因素回归分析确定了有和没有既往减肥手术患者的特征差异,并使用独立危险因素构建这些结局的多变量逻辑回归模型。
共确定了40685例患有慢性胰腺炎且严重肥胖或有减肥手术史的患者,其中31.4%的患者曾接受过减肥手术。与仅患有严重肥胖的个体相比,有既往减肥手术史的慢性胰腺炎患者的Charlson合并症评分更低(1.6±1.7对2.85±2.3)。减肥手术与再入院风险较高相关(OR:1.77[1.64,1.91],p<0.05)。虽然两组之间在死亡率方面没有发现显著差异(5.4%对4.8%,OR:1.10[0.97,1.25],p=0.15),但蛋白质营养不良与术后患者死亡率显著增加相关(OR:2.35,95%CI[2.06,2.70])。
与从未接受过减肥手术的肥胖慢性胰腺炎患者相比,代谢手术增加了慢性胰腺炎患者的再入院风险。然而,它并没有改变死亡率。需要进一步的前瞻性研究来探索潜在机制和预防策略。